Cambrex to Present at Upcoming Investor Conferences in September

EAST RUTHERFORD, N.J., Aug. 26, 2016 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), is pleased to announce that company management will present at the following investor conferences in September:

The live audio webcasts and slide presentations can be accessed from the Cambrex website at www.cambrex.com in the Investors section under “Webcasts & Presentations”, and replays will be available for 90 days after the live events conclude. 

About CambrexCambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics.  The Company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products.  For more information, please visit www.cambrex.com.

Contact:
Stephanie LaFiura
Investor Relations Associate
Phone:  201.804.3037
Email:  [email protected]

You May Also Be Interested In

• AZZ, Inc. (AZZ) Announces Proposed 4M Share Offering
• WHEELHOUSE SECURES MINORITY INVESTMENT FROM ALIGNMENT GROWTH TO SCALE THE NEXT GENERATION ENTERTAINMENT COMPANY
• Avanos Medical, Inc. to Webcast Conference Call Discussing First Quarter 2024 Financial Results